Therapix Biosciences (NASDAQ: TRPX ) has entered into definitive agreements with several institutional investorsproviding for the issuance of an aggregate of 642,853 ADS at a price of $3.50/ADS in a registered direct offering. More news on: Therapix Biosciences Ltd., Healthcare sto…